You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):傳奇生物將於2025年美國臨牀腫瘤學會及歐洲血液學協會年會公佈用於治療多發性骨髓瘤患者的CARVYKTI最新資料
格隆匯 05-23 07:36

格隆匯5月23日丨金斯瑞生物科技(01548.HK)發佈公吿,公司聯營公司傳奇生物科技股份有限公司(“傳奇生物”,其股份以美國存托股份形式於美國納斯達克全球精選市場上市)已於2025年5月22日(紐約時間)(2025年5月23日香港交易時段前)向美國證券交易委員會(“美國證監會”)提交6-K表格,並宣佈將於2025年美國臨牀腫瘤學會年會(“ASCO”)和歐洲血液學協會(“EHA”)大會上公佈CARTITUDE臨牀開發項目最新資料,該項目評估用於治療多發性骨髓瘤患者的 CARVYKTI®(西達基奧侖賽,英文通用名 ciltacabtagene autoleucel,簡稱 cilta-cel)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account